USPTO serial 79337694
Reviewed by CopyMark Law Group
These status codes mean the trademark application is abandoned and no longer pending. Common reasons include missing an Office Action response (600), filing without a valid basis (602), express abandonment by the applicant (604), or failure to respond to an examiner's inquiry (618). Revival may be possible in limited circumstances. If abandonment was unintentional, consult counsel about a petition to revive. Otherwise file a new application if protection is still needed.
If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.
| Class | Description | Status | First use |
|---|---|---|---|
| 009 | Biochips for research or scientific purposes; bioreactor for cell culturing; bioreactors for laboratory use; bioreactors for medical research use; cell culture apparatus for laboratory use, namely, cell culture dishes; laboratory devices for analyzing genome information; devices for analyzing protein sequence used as laboratory apparatus; DNA chips; DNA microarray; non-medical imaging devices for scientific purposes; non-medical immunostaining instruments for scientific purposes; non-medical incubation plates for scientific or laboratory use; incubators for laboratory use; non-medical diagnostic instruments for DNA analysis for scientific research use, not for medical use; laboratory apparatus and instruments for extracting DNA; laboratory incubators other than for medical use; laboratory instruments in the nature of cell sorter, flow cytometer, cell isolator, cell counter and liquid dispensers other than for medical use; laboratory optical apparatus, namely, optical mirrors; LED microscopes; non-medical lasers for scientific use; lenses for microscopes; microarray slides for laboratory use; microplate readers; microscope slides; glassware models for scientific experiments in laboratories; nucleic acid sequencers for scientific purposes; petri dishes; petri dishes used in laboratory research; pipette tips; pipettes; scientific distillation apparatus and instruments; print heads for inkjet document printers; disposable plastic bioreactors for cell culture; bioreactors for cell culture; laboratory apparatus for fabrication of three-dimensional tissues and organs; scientific research and laboratory apparatus and instruments in the nature of cell sorters, flow cytometers, cell isolators, cell counters and liquid dispensers in the field of cytology; equipment for scientific research and laboratory apparatus and instruments in the name of cell sorters, flow cytometers, cell isolators, cell counters, liquid dispensers in the field of cytology; scientific research and laboratory apparatus, namely, cell handling apparatus in the nature of petri dishes, cell analysis and cell separation apparatus in the nature of flow cytometers and flow-based analyzers providing cell and particle analysis, detection, or counting; scientific research and laboratory apparatus, namely, cell culture apparatus in the nature of petri dishes for laboratory use; laboratory apparatus and instruments in the nature of biochips for use in biopharmaceutical discovery and development for research or scientific purposes; laboratory apparatus and instruments in the nature of biochips for use in cell detection and molecular discovery for research or scientific purposes; laboratory apparatus and instruments for the analysis, retrieval or discovery of single cells; laboratory apparatus and instruments for use in assuring monoclonality; parts and fittings for all the aforesaid goods; laboratory apparatus for fabrication of three dimensional (3D) living tissues; laboratory equipment for scientific and research use, namely, systems comprised of fluid dispenser, imaging station, computer hardware, control software, analysis for software, chips and reagents | ACTIVE | — |
| 010 | Tools for medical diagnostics of cancer, autoimmune disease, heart disease, brain disease, respiratory disease; diagnostic apparatus for use in the diagnosis of cancer, autoimmune disease, heart disease, brain disease, liver disease, respiratory disease for medical purposes; diagnostic instruments for use in the diagnosis of cancer, autoimmune disease, heart disease, brain disease, liver disease, respiratory disease for medical use; testing probes for medical diagnostic purposes, diagnostic imaging apparatus for medical use; optical imaging apparatus for medical diagnostic use; membrane test plates for use in medical diagnostics; apparatus for carrying out diagnostic tests of cancer, autoimmune disease, heart disease, brain disease, liver disease, respiratory disease and for prenatal testing for medical purposes; cell culture instruments for medical use, namely, cell culture chambers; inkjet based medical devices for use in medical research and genetic research and in the medical fields where molecular or cell separations is needed; medical diagnostic testing apparatus in the nature of cell sorters, flow cytometers, cell isolators, cell counters, liquid dispensers for use in immuno-assay procedures; medical diagnostic testing instruments in the nature of cell sorters, flow cytometers, cell isolators, cell counters, liquid dispensers for immunoassay procedures; medical apparatus and instruments in the fields of cytology, namely, cell sorters, flow cytometers, cell isolators, cell counters, liquid dispensers | ACTIVE | — |
| 042 | Biological research, scientific clinical research and medical research; biomedical research services; scientific clinical research; development of pharmaceutical preparations and medicines; laboratory research services relating to pharmaceuticals; laboratory research services relating to dermatology; laboratory research services relating to the production of monoclonal antibodies; medical laboratory services; medical research; pharmaceutical drug development services; pharmaceutical product evaluation; pharmaceutical products development; pharmaceutical research and development; pharmaceutical research services; scientific research and development for the pharmaceutical industry; research and development in the pharmaceutical and biotechnology fields; research and development of vaccines and medicines; scientific research and development; scientific research for medical purposes in the area of cancerous diseases; scientific research in the field of pharmacy; services in the nature of pharmaceutical production, namely, development of pharmaceutical preparations; evaluation for assessing the efficiency of pharmaceuticals; services in the nature of product quality evaluation for assessing the efficiency of veterinary drugs; testing of pharmaceuticals; research and development services in the field of antibodies; research and development in the field of microorganisms and cells; scientific laboratory services relating to the isolation and cultivation of human tissues and cells; medical research relating to medicine; medical research relating to medicines; design and development of diagnostic apparatus; design of diagnostic apparatus and equipment; design and development of medical diagnostic apparatus; research and development in the field of diagnostic preparations; research and development services in the field of cytology; biotechnology research; biotechnology testing for scientific research purposes; research and development in the field of biotechnology; research relating to biotechnology; consultancy relating to biotechnology; consultancy in the field of biotechnology; scientific and medical research and development in the field of cytology; scientific and medical research and development in the field of bioprinting | ACTIVE | — |
CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.
| Date | Code | Event | What it means |
|---|---|---|---|
| Feb 14, 2024 | FINT | FINAL DECISION TRANSACTION PROCESSED BY IB | — |
| Jan 24, 2024 | FICS | FINAL DISPOSITION NOTICE SENT TO IB | — |
| Jan 24, 2024 | FICR | FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB | — |
| Oct 3, 2023 | OPNX | NOTIFICATION OF POSSIBLE OPPOSITION - PROCESSED BY IB | — |
| Sep 13, 2023 | OPNS | NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB | — |
| Sep 13, 2023 | OPNR | NOTIFICATION OF POSSIBLE OPPOSITION CREATED, TO BE SENT TO IB | — |
| Aug 19, 2023 | NREP | NEW REPRESENTATIVE AT IB RECEIVED | — |
| Jan 24, 2023 | MAB2 | ABANDONMENT NOTICE MAILED - FAILURE TO RESPOND | The trademark application was abandoned because a required response or document was not filed by the deadline — usually a missed Office Action response. The application is dead unless a petition to revive is granted within a limited time. |
| Jan 24, 2023 | MAB2 | ABANDONMENT NOTICE MAILED - FAILURE TO RESPOND | The trademark application was abandoned because a required response or document was not filed by the deadline — usually a missed Office Action response. The application is dead unless a petition to revive is granted within a limited time. |
| Jan 24, 2023 | ABN2 | ABANDONMENT - FAILURE TO RESPOND OR LATE RESPONSE | The trademark application was abandoned because a required response or document was not filed by the deadline — usually a missed Office Action response. The application is dead unless a petition to revive is granted within a limited time. |
| Aug 2, 2022 | RFNT | REFUSAL PROCESSED BY IB | — |
| Jul 12, 2022 | RFCS | NON-FINAL ACTION MAILED - REFUSAL SENT TO IB | — |
| Jul 12, 2022 | RFRR | REFUSAL PROCESSED BY MPU | — |
| Jul 7, 2022 | RFCR | NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW | — |
| Jul 6, 2022 | CNRT | NON-FINAL ACTION WRITTEN | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Jun 29, 2022 | DOCK | ASSIGNED TO EXAMINER | — |
| Apr 12, 2022 | MAFR | APPLICATION FILING RECEIPT MAILED | — |
| Apr 8, 2022 | NWOS | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | — |
| Apr 7, 2022 | REPR | SN ASSIGNED FOR SECT 66A APPL FROM IB | — |